Back to Oxytocin research
oxytocin other rct n=524 2020-05-01 ClinicalTrials

Comparing Immediate vs. Expectant Oxytocin for Prelabor Rupture of Membranes at Term

Management of Prelabor Rupture of the Membranes at Term

Background

Prelabor Rupture of Membranes (PROM) at term, where the amniotic sac breaks before labor begins, is a common obstetric complication affecting approximately 8-10% of pregnancies. Prolonged rupture of membranes significantly increases the risk of maternal infections like chorioamnionitis (inflammation of the fetal membranes) and endometritis (inflammation of the uterine lining), as well as fetal infection and cesarean section complications. This study aims to determine whether immediate labor augmentation with oxytocin is more effective than waiting for spontaneous labor for up to 24 hours in managing PROM at term, addressing a critical gap in optimal clinical protocols.

Results

As this study is currently recruiting an estimated 524 participants, specific findings regarding the comparative efficacy of the two protocols are not yet available. However, the investigators are rigorously evaluating whether immediate labor augmentation with oxytocin significantly reduces adverse outcomes when compared to expectant management for up to 24 hours. > The primary objective is to assess if early oxytocin intervention leads to a statistically significant lower incidence of maternal and fetal infections and cesarean section complications. They will quantitatively compare the rates of specific adverse events, including chorioamnionitis (inflammation of the fetal membranes), endometritis (inflammation of the uterine lining), fetal infection, and the overall need for cesarean section, between the two distinct management protocols. The study hypothesizes that the immediate intervention group will demonstrate a superior safety profile, potentially leading to improved health outcomes for both mothers and newborns.

Why It Matters

The findings from this randomized controlled trial are crucial for optimizing the management of prelabor rupture of membranes at term, a condition that impacts thousands of pregnancies annually. If immediate oxytocin augmentation proves superior in reducing complications, it could establish a new standard of care, potentially reducing maternal and fetal morbidity associated with prolonged PROM. This could lead to updated clinical guidelines, improving outcomes for countless pregnancies worldwide and enhancing the safety of childbirth. Given its pragmatic design, positive results could be directly implemented into obstetric practice without requiring further trial phases.


oxytocin other safety data present
Source: clinicaltrials:NCT04307069 · Ingested 2026-04-24 · Digest: gemini-2.5-flash